{"id":288875,"date":"2026-06-01T12:00:00","date_gmt":"2026-06-01T10:00:00","guid":{"rendered":"https:\/\/geneveinfos.ch\/2026\/06\/01\/mindmaze-secures-chf-8-million-to-expand-its-neurotherapeutics-platform\/"},"modified":"2026-11-09T13:37:17","modified_gmt":"2026-11-09T12:37:17","slug":"mindmaze-secures-chf-8-million-to-expand-its-neurotherapeutics-platform","status":"publish","type":"post","link":"https:\/\/geneveinfos.ch\/en\/2026\/06\/01\/mindmaze-secures-chf-8-million-to-expand-its-neurotherapeutics-platform\/","title":{"rendered":"MindMaze Therapeutics raises 8 million from Neuro.io Group"},"content":{"rendered":"<p class=\"gi-temps\">\u23f1 1 min read<\/p>\n<h3>Background<\/h3>\n<p>MindMaze Therapeutics is a Geneva-based company specialising in scalable precision neurotherapeutics.<\/p>\n<h3>The key points<\/h3>\n<p>MindMaze Therapeutics has signed an 8 million franc equity financing agreement with Neuro.io Group. The deal gives Neuro.io a strategic stake in the company, according to GGBa.<\/p>\n<p>The funds will be used to expand MindMaze Therapeutics' presence in the United States and deploy its solutions more widely. The financing should strengthen the company's balance sheet as it scales up.<\/p>\n<h3>Key figures<\/h3>\n<ul>\n<li>8 million francs in equity financing.<\/li>\n<li>Two tranches: treasury share purchases and mandatory convertible loan notes.<\/li>\n<li>Close to 30 million ordinary shares expected after conversion, over twelve months.<\/li>\n<\/ul>\n<h3>What it means for businesses<\/h3>\n<p>The two parties have signed a letter of intent to explore several strategic options, including a possible business combination. Talks are to pair MindMaze Therapeutics' clinically validated neurotherapeutics platform with Neuro.io's healthcare AI capabilities.<\/p>\n<h3>What's next<\/h3>\n<p>The stated aim is to develop AI-enabled interventions for neurological disorders.<\/p>\n<h3>Read also<\/h3>\n<ul class=\"gi-related\">\n<li><a href=\"https:\/\/geneveinfos.ch\/en\/2026\/07\/06\/geneva-named-european-capital-of-brain-health-2026\/\">Brain health: Geneva named European capital 2026<\/a><\/li>\n<li><a href=\"https:\/\/geneveinfos.ch\/en\/2026\/08\/03\/immitra-bio-raises-chf-2-4-million-to-advance-its-in-vivo-gene-editing-platform\/\">Immitra Bio raises 2.4 million for in-vivo gene editing<\/a><\/li>\n<\/ul>\n<h3>Sources<\/h3>\n<ul class=\"gi-sources\">\n<li><a href=\"https:\/\/ggba.swiss\/en\/mindmaze-secures-chf-8-million-to-expand-its-neurotherapeutics-platform\/\">GGBa \u2013 MindMaze secures CHF 8 million to expand its neurotherapeutics platform<\/a><\/li>\n<\/ul>","protected":false},"excerpt":{"rendered":"<p>MindMaze Therapeutics has signed an 8 million franc equity financing agreement with Neuro.io Group.<\/p>","protected":false},"author":4,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[102],"tags":[127],"class_list":["post-288875","post","type-post","status-publish","format-standard","hentry","category-pharma-biotech","tag-fiche-bilingue"],"aioseo_notices":[],"aioseo_head":"\n\t\t<!-- All in One SEO 5.0.5 - aioseo.com -->\n\t<meta name=\"description\" content=\"MindMaze Therapeutics, \u00e0 Gen\u00e8ve, l\u00e8ve 8 millions de francs aupr\u00e8s de Neuro.io Group pour s&#039;\u00e9tendre aux \u00c9tats-Unis et \u00e9tudie un rapprochement.\" \/>\n\t<meta name=\"robots\" content=\"max-image-preview:large\" \/>\n\t<meta name=\"author\" content=\"R\u00e9daction Gen\u00e8ve Infos\"\/>\n\t<link rel=\"canonical\" href=\"https:\/\/geneveinfos.ch\/en\/2026\/06\/01\/mindmaze-secures-chf-8-million-to-expand-its-neurotherapeutics-platform\/\" \/>\n\t\t<meta name=\"generator\" content=\"All in One SEO (AIOSEO) 5.0.5\" \/>\n\t\t<meta property=\"og:locale\" content=\"en_GB\" \/>\n\t\t<meta property=\"og:site_name\" content=\"Gen\u00e8ve Infos - Le site d&#039;informations de la r\u00e9gion genevoise\" \/>\n\t\t<meta property=\"og:type\" content=\"article\" \/>\n\t\t<meta property=\"og:title\" content=\"MindMaze Therapeutics l\u00e8ve 8 millions aupr\u00e8s de Neuro.io Group - Gen\u00e8ve Infos\" \/>\n\t\t<meta property=\"og:description\" content=\"MindMaze Therapeutics, \u00e0 Gen\u00e8ve, l\u00e8ve 8 millions de francs aupr\u00e8s de Neuro.io Group pour s&#039;\u00e9tendre aux \u00c9tats-Unis et \u00e9tudie un rapprochement.\" \/>\n\t\t<meta property=\"og:url\" content=\"https:\/\/geneveinfos.ch\/en\/2026\/06\/01\/mindmaze-secures-chf-8-million-to-expand-its-neurotherapeutics-platform\/\" \/>\n\t\t<meta property=\"og:image\" content=\"https:\/\/geneveinfos.ch\/wp-content\/uploads\/2026\/10\/geneveinfos-partage-1200x630-1.jpg\" \/>\n\t\t<meta property=\"og:image:secure_url\" content=\"https:\/\/geneveinfos.ch\/wp-content\/uploads\/2026\/10\/geneveinfos-partage-1200x630-1.jpg\" \/>\n\t\t<meta property=\"og:image:width\" content=\"1200\" \/>\n\t\t<meta property=\"og:image:height\" content=\"630\" \/>\n\t\t<meta property=\"article:published_time\" content=\"2026-06-01T10:00:00+00:00\" \/>\n\t\t<meta property=\"article:modified_time\" content=\"2026-11-09T12:37:17+00:00\" \/>\n\t\t<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/profile.php?id=61576016541234\" \/>\n\t\t<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n\t\t<meta name=\"twitter:title\" content=\"MindMaze Therapeutics l\u00e8ve 8 millions aupr\u00e8s de Neuro.io Group - Gen\u00e8ve Infos\" \/>\n\t\t<meta name=\"twitter:description\" content=\"MindMaze Therapeutics, \u00e0 Gen\u00e8ve, l\u00e8ve 8 millions de francs aupr\u00e8s de Neuro.io Group pour s&#039;\u00e9tendre aux \u00c9tats-Unis et \u00e9tudie un rapprochement.\" \/>\n\t\t<meta name=\"twitter:image\" content=\"https:\/\/geneveinfos.ch\/wp-content\/uploads\/2026\/10\/geneveinfos-partage-1200x630-1.jpg\" \/>\n\t\t<script type=\"application\/ld+json\" class=\"aioseo-schema\">\n\t\t\t{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/geneveinfos.ch\\\/en\\\/2026\\\/06\\\/01\\\/mindmaze-secures-chf-8-million-to-expand-its-neurotherapeutics-platform\\\/#breadcrumblist\",\"itemListElement\":[{\"@type\":\"ListItem\",\"@id\":\"https:\\\/\\\/geneveinfos.ch\\\/en\\\/#listItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/geneveinfos.ch\\\/en\\\/\",\"nextItem\":{\"@type\":\"ListItem\",\"@id\":\"https:\\\/\\\/geneveinfos.ch\\\/en\\\/category\\\/pharma-biotech\\\/#listItem\",\"name\":\"Pharma &amp; biotech\"}},{\"@type\":\"ListItem\",\"@id\":\"https:\\\/\\\/geneveinfos.ch\\\/en\\\/category\\\/pharma-biotech\\\/#listItem\",\"position\":2,\"name\":\"Pharma &amp; biotech\",\"item\":\"https:\\\/\\\/geneveinfos.ch\\\/en\\\/category\\\/pharma-biotech\\\/\",\"nextItem\":{\"@type\":\"ListItem\",\"@id\":\"https:\\\/\\\/geneveinfos.ch\\\/en\\\/2026\\\/06\\\/01\\\/mindmaze-secures-chf-8-million-to-expand-its-neurotherapeutics-platform\\\/#listItem\",\"name\":\"MindMaze Therapeutics l\\u00e8ve 8 millions aupr\\u00e8s de Neuro.io Group\"},\"previousItem\":{\"@type\":\"ListItem\",\"@id\":\"https:\\\/\\\/geneveinfos.ch\\\/en\\\/#listItem\",\"name\":\"Home\"}},{\"@type\":\"ListItem\",\"@id\":\"https:\\\/\\\/geneveinfos.ch\\\/en\\\/2026\\\/06\\\/01\\\/mindmaze-secures-chf-8-million-to-expand-its-neurotherapeutics-platform\\\/#listItem\",\"position\":3,\"name\":\"MindMaze Therapeutics l\\u00e8ve 8 millions aupr\\u00e8s de Neuro.io Group\",\"previousItem\":{\"@type\":\"ListItem\",\"@id\":\"https:\\\/\\\/geneveinfos.ch\\\/en\\\/category\\\/pharma-biotech\\\/#listItem\",\"name\":\"Pharma &amp; biotech\"}}]},{\"@type\":\"NewsArticle\",\"@id\":\"https:\\\/\\\/geneveinfos.ch\\\/en\\\/2026\\\/06\\\/01\\\/mindmaze-secures-chf-8-million-to-expand-its-neurotherapeutics-platform\\\/#newsarticle\",\"name\":\"MindMaze Therapeutics l\\u00e8ve 8 millions aupr\\u00e8s de Neuro.io Group - Gen\\u00e8ve Infos\",\"headline\":\"MindMaze Therapeutics l\\u00e8ve 8 millions aupr\\u00e8s de Neuro.io Group\",\"author\":{\"@id\":\"https:\\\/\\\/geneveinfos.ch\\\/en\\\/author\\\/redaction-geneve-infos\\\/#author\"},\"publisher\":{\"@id\":\"https:\\\/\\\/geneveinfos.ch\\\/en\\\/#organization\"},\"image\":{\"@type\":\"ImageObject\",\"url\":\"https:\\\/\\\/geneveinfos.ch\\\/wp-content\\\/uploads\\\/2025\\\/04\\\/geneve_infos_logo.png\",\"@id\":\"https:\\\/\\\/geneveinfos.ch\\\/en\\\/#articleImage\"},\"datePublished\":\"2026-06-01T12:00:00+02:00\",\"dateModified\":\"2026-11-09T13:37:17+01:00\",\"inLanguage\":\"en-GB\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/geneveinfos.ch\\\/en\\\/2026\\\/06\\\/01\\\/mindmaze-secures-chf-8-million-to-expand-its-neurotherapeutics-platform\\\/#webpage\"},\"isPartOf\":{\"@id\":\"https:\\\/\\\/geneveinfos.ch\\\/en\\\/2026\\\/06\\\/01\\\/mindmaze-secures-chf-8-million-to-expand-its-neurotherapeutics-platform\\\/#webpage\"},\"articleSection\":\"Pharma &amp; biotech, Fiche bilingue\",\"dateline\":\"Published on June 1, 2026.\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/geneveinfos.ch\\\/en\\\/#organization\",\"name\":\"Gen\\u00e8ve Infos\",\"description\":\"Revue de presse et analyses sur l'\\u00e9conomie et l'urbanisme de Gen\\u00e8ve.\",\"url\":\"https:\\\/\\\/geneveinfos.ch\\\/en\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"url\":\"https:\\\/\\\/geneveinfos.ch\\\/wp-content\\\/uploads\\\/2025\\\/04\\\/geneve_infos_logo.png\",\"@id\":\"https:\\\/\\\/geneveinfos.ch\\\/en\\\/2026\\\/06\\\/01\\\/mindmaze-secures-chf-8-million-to-expand-its-neurotherapeutics-platform\\\/#organizationLogo\"},\"image\":{\"@id\":\"https:\\\/\\\/geneveinfos.ch\\\/en\\\/2026\\\/06\\\/01\\\/mindmaze-secures-chf-8-million-to-expand-its-neurotherapeutics-platform\\\/#organizationLogo\"},\"sameAs\":[\"https:\\\/\\\/www.facebook.com\\\/profile.php?id=61576016541234\",\"https:\\\/\\\/www.instagram.com\\\/geneveinfos.ch?igsh=MXhkaTV2bXBkZm00NQ==\",\"https:\\\/\\\/www.linkedin.com\\\/company\\\/geneveinfos-ch\"]},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/geneveinfos.ch\\\/en\\\/author\\\/redaction-geneve-infos\\\/#author\",\"url\":\"https:\\\/\\\/geneveinfos.ch\\\/en\\\/author\\\/redaction-geneve-infos\\\/\",\"name\":\"R\\u00e9daction Gen\\u00e8ve Infos\",\"image\":{\"@type\":\"ImageObject\",\"@id\":\"https:\\\/\\\/geneveinfos.ch\\\/en\\\/2026\\\/06\\\/01\\\/mindmaze-secures-chf-8-million-to-expand-its-neurotherapeutics-platform\\\/#authorImage\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/4a611ac9406717aef02499144d0e12a8f5e1327b66a2e6023de2c094c4937e1d?s=96&d=mm&r=g\",\"width\":96,\"height\":96,\"caption\":\"R\\u00e9daction Gen\\u00e8ve Infos\"}},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/geneveinfos.ch\\\/en\\\/2026\\\/06\\\/01\\\/mindmaze-secures-chf-8-million-to-expand-its-neurotherapeutics-platform\\\/#webpage\",\"url\":\"https:\\\/\\\/geneveinfos.ch\\\/en\\\/2026\\\/06\\\/01\\\/mindmaze-secures-chf-8-million-to-expand-its-neurotherapeutics-platform\\\/\",\"name\":\"MindMaze Therapeutics l\\u00e8ve 8 millions aupr\\u00e8s de Neuro.io Group - Gen\\u00e8ve Infos\",\"description\":\"MindMaze Therapeutics, \\u00e0 Gen\\u00e8ve, l\\u00e8ve 8 millions de francs aupr\\u00e8s de Neuro.io Group pour s'\\u00e9tendre aux \\u00c9tats-Unis et \\u00e9tudie un rapprochement.\",\"inLanguage\":\"en-GB\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/geneveinfos.ch\\\/en\\\/#website\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/geneveinfos.ch\\\/en\\\/2026\\\/06\\\/01\\\/mindmaze-secures-chf-8-million-to-expand-its-neurotherapeutics-platform\\\/#breadcrumblist\"},\"author\":{\"@id\":\"https:\\\/\\\/geneveinfos.ch\\\/en\\\/author\\\/redaction-geneve-infos\\\/#author\"},\"creator\":{\"@id\":\"https:\\\/\\\/geneveinfos.ch\\\/en\\\/author\\\/redaction-geneve-infos\\\/#author\"},\"datePublished\":\"2026-06-01T12:00:00+02:00\",\"dateModified\":\"2026-11-09T13:37:17+01:00\"},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/geneveinfos.ch\\\/en\\\/#website\",\"url\":\"https:\\\/\\\/geneveinfos.ch\\\/en\\\/\",\"name\":\"Gen\\u00e8ve Infos\",\"description\":\"Le site d'informations de la r\\u00e9gion genevoise\",\"inLanguage\":\"en-GB\",\"publisher\":{\"@id\":\"https:\\\/\\\/geneveinfos.ch\\\/en\\\/#organization\"}}]}\n\t\t<\/script>\n\t\t<!-- All in One SEO -->\n\n","aioseo_head_json":{"title":"MindMaze Therapeutics raises 8 million from Neuro.io Group - Gen\u00e8ve Infos","description":"MindMaze Therapeutics, in Geneva, raises 8 million francs from Neuro.io Group to expand in the United States and explores a combination.","canonical_url":"https:\/\/geneveinfos.ch\/en\/2026\/06\/01\/mindmaze-secures-chf-8-million-to-expand-its-neurotherapeutics-platform\/","robots":"max-image-preview:large","keywords":"","webmasterTools":{"miscellaneous":""},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"BreadcrumbList","@id":"https:\/\/geneveinfos.ch\/en\/2026\/06\/01\/mindmaze-secures-chf-8-million-to-expand-its-neurotherapeutics-platform\/#breadcrumblist","itemListElement":[{"@type":"ListItem","@id":"https:\/\/geneveinfos.ch\/en\/#listItem","position":1,"name":"Home","item":"https:\/\/geneveinfos.ch\/en\/","nextItem":{"@type":"ListItem","@id":"https:\/\/geneveinfos.ch\/en\/category\/pharma-biotech\/#listItem","name":"Pharma &amp; biotech"}},{"@type":"ListItem","@id":"https:\/\/geneveinfos.ch\/en\/category\/pharma-biotech\/#listItem","position":2,"name":"Pharma &amp; biotech","item":"https:\/\/geneveinfos.ch\/en\/category\/pharma-biotech\/","nextItem":{"@type":"ListItem","@id":"https:\/\/geneveinfos.ch\/en\/2026\/06\/01\/mindmaze-secures-chf-8-million-to-expand-its-neurotherapeutics-platform\/#listItem","name":"MindMaze Therapeutics l\u00e8ve 8 millions aupr\u00e8s de Neuro.io Group"},"previousItem":{"@type":"ListItem","@id":"https:\/\/geneveinfos.ch\/en\/#listItem","name":"Home"}},{"@type":"ListItem","@id":"https:\/\/geneveinfos.ch\/en\/2026\/06\/01\/mindmaze-secures-chf-8-million-to-expand-its-neurotherapeutics-platform\/#listItem","position":3,"name":"MindMaze Therapeutics l\u00e8ve 8 millions aupr\u00e8s de Neuro.io Group","previousItem":{"@type":"ListItem","@id":"https:\/\/geneveinfos.ch\/en\/category\/pharma-biotech\/#listItem","name":"Pharma &amp; biotech"}}]},{"@type":"NewsArticle","@id":"https:\/\/geneveinfos.ch\/en\/2026\/06\/01\/mindmaze-secures-chf-8-million-to-expand-its-neurotherapeutics-platform\/#newsarticle","name":"MindMaze Therapeutics l\u00e8ve 8 millions aupr\u00e8s de Neuro.io Group - Gen\u00e8ve Infos","headline":"MindMaze Therapeutics l\u00e8ve 8 millions aupr\u00e8s de Neuro.io Group","author":{"@id":"https:\/\/geneveinfos.ch\/en\/author\/redaction-geneve-infos\/#author"},"publisher":{"@id":"https:\/\/geneveinfos.ch\/en\/#organization"},"image":{"@type":"ImageObject","url":"https:\/\/geneveinfos.ch\/wp-content\/uploads\/2025\/04\/geneve_infos_logo.png","@id":"https:\/\/geneveinfos.ch\/en\/#articleImage"},"datePublished":"2026-06-01T12:00:00+02:00","dateModified":"2026-11-09T13:37:17+01:00","inLanguage":"en-GB","mainEntityOfPage":{"@id":"https:\/\/geneveinfos.ch\/en\/2026\/06\/01\/mindmaze-secures-chf-8-million-to-expand-its-neurotherapeutics-platform\/#webpage"},"isPartOf":{"@id":"https:\/\/geneveinfos.ch\/en\/2026\/06\/01\/mindmaze-secures-chf-8-million-to-expand-its-neurotherapeutics-platform\/#webpage"},"articleSection":"Pharma &amp; biotech, Fiche bilingue","dateline":"Published on June 1, 2026."},{"@type":"Organization","@id":"https:\/\/geneveinfos.ch\/en\/#organization","name":"Gen\u00e8ve Infos","description":"Revue de presse et analyses sur l'\u00e9conomie et l'urbanisme de Gen\u00e8ve.","url":"https:\/\/geneveinfos.ch\/en\/","logo":{"@type":"ImageObject","url":"https:\/\/geneveinfos.ch\/wp-content\/uploads\/2025\/04\/geneve_infos_logo.png","@id":"https:\/\/geneveinfos.ch\/en\/2026\/06\/01\/mindmaze-secures-chf-8-million-to-expand-its-neurotherapeutics-platform\/#organizationLogo"},"image":{"@id":"https:\/\/geneveinfos.ch\/en\/2026\/06\/01\/mindmaze-secures-chf-8-million-to-expand-its-neurotherapeutics-platform\/#organizationLogo"},"sameAs":["https:\/\/www.facebook.com\/profile.php?id=61576016541234","https:\/\/www.instagram.com\/geneveinfos.ch?igsh=MXhkaTV2bXBkZm00NQ==","https:\/\/www.linkedin.com\/company\/geneveinfos-ch"]},{"@type":"Person","@id":"https:\/\/geneveinfos.ch\/en\/author\/redaction-geneve-infos\/#author","url":"https:\/\/geneveinfos.ch\/en\/author\/redaction-geneve-infos\/","name":"R\u00e9daction Gen\u00e8ve Infos","image":{"@type":"ImageObject","@id":"https:\/\/geneveinfos.ch\/en\/2026\/06\/01\/mindmaze-secures-chf-8-million-to-expand-its-neurotherapeutics-platform\/#authorImage","url":"https:\/\/secure.gravatar.com\/avatar\/4a611ac9406717aef02499144d0e12a8f5e1327b66a2e6023de2c094c4937e1d?s=96&d=mm&r=g","width":96,"height":96,"caption":"R\u00e9daction Gen\u00e8ve Infos"}},{"@type":"WebPage","@id":"https:\/\/geneveinfos.ch\/en\/2026\/06\/01\/mindmaze-secures-chf-8-million-to-expand-its-neurotherapeutics-platform\/#webpage","url":"https:\/\/geneveinfos.ch\/en\/2026\/06\/01\/mindmaze-secures-chf-8-million-to-expand-its-neurotherapeutics-platform\/","name":"MindMaze Therapeutics l\u00e8ve 8 millions aupr\u00e8s de Neuro.io Group - Gen\u00e8ve Infos","description":"MindMaze Therapeutics, \u00e0 Gen\u00e8ve, l\u00e8ve 8 millions de francs aupr\u00e8s de Neuro.io Group pour s'\u00e9tendre aux \u00c9tats-Unis et \u00e9tudie un rapprochement.","inLanguage":"en-GB","isPartOf":{"@id":"https:\/\/geneveinfos.ch\/en\/#website"},"breadcrumb":{"@id":"https:\/\/geneveinfos.ch\/en\/2026\/06\/01\/mindmaze-secures-chf-8-million-to-expand-its-neurotherapeutics-platform\/#breadcrumblist"},"author":{"@id":"https:\/\/geneveinfos.ch\/en\/author\/redaction-geneve-infos\/#author"},"creator":{"@id":"https:\/\/geneveinfos.ch\/en\/author\/redaction-geneve-infos\/#author"},"datePublished":"2026-06-01T12:00:00+02:00","dateModified":"2026-11-09T13:37:17+01:00"},{"@type":"WebSite","@id":"https:\/\/geneveinfos.ch\/en\/#website","url":"https:\/\/geneveinfos.ch\/en\/","name":"Gen\u00e8ve Infos","description":"Le site d'informations de la r\u00e9gion genevoise","inLanguage":"en-GB","publisher":{"@id":"https:\/\/geneveinfos.ch\/en\/#organization"}}]},"og:locale":"en_GB","og:site_name":"Gen\u00e8ve Infos - Le site d'informations de la r\u00e9gion genevoise","og:type":"article","og:title":"MindMaze Therapeutics l\u00e8ve 8 millions aupr\u00e8s de Neuro.io Group - Gen\u00e8ve Infos","og:description":"MindMaze Therapeutics, \u00e0 Gen\u00e8ve, l\u00e8ve 8 millions de francs aupr\u00e8s de Neuro.io Group pour s'\u00e9tendre aux \u00c9tats-Unis et \u00e9tudie un rapprochement.","og:url":"https:\/\/geneveinfos.ch\/en\/2026\/06\/01\/mindmaze-secures-chf-8-million-to-expand-its-neurotherapeutics-platform\/","og:image":"https:\/\/geneveinfos.ch\/wp-content\/uploads\/2026\/10\/geneveinfos-partage-1200x630-1.jpg","og:image:secure_url":"https:\/\/geneveinfos.ch\/wp-content\/uploads\/2026\/10\/geneveinfos-partage-1200x630-1.jpg","og:image:width":1200,"og:image:height":630,"article:published_time":"2026-06-01T10:00:00+00:00","article:modified_time":"2026-11-09T12:37:17+00:00","article:publisher":"https:\/\/www.facebook.com\/profile.php?id=61576016541234","twitter:card":"summary_large_image","twitter:title":"MindMaze Therapeutics l\u00e8ve 8 millions aupr\u00e8s de Neuro.io Group - Gen\u00e8ve Infos","twitter:description":"MindMaze Therapeutics, \u00e0 Gen\u00e8ve, l\u00e8ve 8 millions de francs aupr\u00e8s de Neuro.io Group pour s'\u00e9tendre aux \u00c9tats-Unis et \u00e9tudie un rapprochement.","twitter:image":"https:\/\/geneveinfos.ch\/wp-content\/uploads\/2026\/10\/geneveinfos-partage-1200x630-1.jpg"},"aioseo_meta_data":{"post_id":"288875","title":null,"description":"MindMaze Therapeutics, in Geneva, raises 8 million francs from Neuro.io Group to expand in the United States and explores a combination.","keywords":null,"keyphrases":null,"primary_term":null,"canonical_url":null,"og_title":null,"og_description":null,"og_object_type":"default","og_image_type":"default","og_image_url":null,"og_image_width":null,"og_image_height":null,"og_image_custom_url":null,"og_image_custom_fields":null,"og_video":null,"og_custom_url":null,"og_article_section":null,"og_article_tags":null,"twitter_use_og":false,"twitter_card":"default","twitter_image_type":"default","twitter_image_url":null,"twitter_image_custom_url":null,"twitter_image_custom_fields":null,"twitter_title":null,"twitter_description":null,"schema":{"blockGraphs":[],"customGraphs":[],"default":{"data":{"Article":[],"Course":[],"Dataset":[],"FAQPage":[],"Movie":[],"Person":[],"Product":[],"ProductReview":[],"Car":[],"Recipe":[],"Service":[],"SoftwareApplication":[],"WebPage":[]},"graphName":"","isEnabled":true},"graphs":[]},"schema_type":"default","schema_type_options":null,"pillar_content":false,"robots_default":true,"robots_noindex":false,"robots_noarchive":false,"robots_nosnippet":false,"robots_nofollow":false,"robots_noimageindex":false,"robots_noodp":false,"robots_notranslate":false,"robots_max_snippet":null,"robots_max_videopreview":null,"robots_max_imagepreview":"large","priority":null,"frequency":null,"local_seo":null,"breadcrumb_settings":null,"limit_modified_date":false,"ai":null,"created":"2026-10-24 13:12:39","updated":"2026-11-09 13:25:39","seo_analyzer_scan_date":null,"focus_keyword":null,"additional_keywords":null,"truseo_locale":null},"aioseo_breadcrumb":"<div class=\"aioseo-breadcrumbs\"><span class=\"aioseo-breadcrumb\">\n\t\t\t<a href=\"https:\/\/geneveinfos.ch\/en\/\" title=\"Home\">Home<\/a>\n\t\t<\/span><span class=\"aioseo-breadcrumb-separator\">\u00bb<\/span><span class=\"aioseo-breadcrumb\">\n\t\t\t<a href=\"https:\/\/geneveinfos.ch\/en\/category\/pharma-biotech\/\" title=\"Pharma &amp; biotech\">Pharma &amp; biotech<\/a>\n\t\t<\/span><span class=\"aioseo-breadcrumb-separator\">\u00bb<\/span><span class=\"aioseo-breadcrumb\">\n\t\t\tMindMaze Therapeutics l\u00e8ve 8 millions aupr\u00e8s de Neuro.io Group\n\t\t<\/span><\/div>","aioseo_breadcrumb_json":[{"label":"Home","link":"https:\/\/geneveinfos.ch\/en\/"},{"label":"Pharma &amp; biotech","link":"https:\/\/geneveinfos.ch\/en\/category\/pharma-biotech\/"},{"label":"MindMaze Therapeutics l\u00e8ve 8 millions aupr\u00e8s de Neuro.io Group","link":"https:\/\/geneveinfos.ch\/en\/2026\/06\/01\/mindmaze-secures-chf-8-million-to-expand-its-neurotherapeutics-platform\/"}],"_links":{"self":[{"href":"https:\/\/geneveinfos.ch\/en\/wp-json\/wp\/v2\/posts\/288875","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/geneveinfos.ch\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/geneveinfos.ch\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/geneveinfos.ch\/en\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/geneveinfos.ch\/en\/wp-json\/wp\/v2\/comments?post=288875"}],"version-history":[{"count":1,"href":"https:\/\/geneveinfos.ch\/en\/wp-json\/wp\/v2\/posts\/288875\/revisions"}],"predecessor-version":[{"id":322703,"href":"https:\/\/geneveinfos.ch\/en\/wp-json\/wp\/v2\/posts\/288875\/revisions\/322703"}],"wp:attachment":[{"href":"https:\/\/geneveinfos.ch\/en\/wp-json\/wp\/v2\/media?parent=288875"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/geneveinfos.ch\/en\/wp-json\/wp\/v2\/categories?post=288875"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/geneveinfos.ch\/en\/wp-json\/wp\/v2\/tags?post=288875"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}